We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Unilabs, Biogen Enter Assay Pact
News

Unilabs, Biogen Enter Assay Pact

Unilabs, Biogen Enter Assay Pact
News

Unilabs, Biogen Enter Assay Pact

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Unilabs, Biogen Enter Assay Pact"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Biogen Idec has selected Unilabs to provide a companion diagnostic anti-JCV antibody assay test, called STRATIFY-JCV.

The test is used to detect anti-JCV antibodies to calculate the risk of Tysabri-treated patients developing progressive multifocal leukoencephalopathy (PML).

To support customers, ordering needs and volume of samples, the two companies have also developed a closed web interface to allow neurologists to order sampling and shipping materials, register courier sample pick up details and request language and format of analytical reports. The project is managed by Unilabs in Copenhagen.

Natascha Schill, director, commercial operations, at Biogen Idec said, “Unilabs is an independent commercial laboratory with a very high reputation, a strong European footprint and excellent international skills, competences and agility. We are very happy to work with Unilabs”

Yvonne Lech, managing director of Unilabs Denmark, added, “The experiences and the innovations created for this project can be applied in the future to create added customer value for future global Companion Diagnostic projects.”

Advertisement